Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Hong Kong Health Experts Say Adolescents Should Receive One Dose Of…
Moderna Inc. (NASDAQ: MRNA) Receives New Drug Submission Approval From Health…
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Receives Written Response Regarding Type…
Silverback Therapeutics Inc. (NASDAQ: SBTX) Reports Phase 1/1b SBT6050 Study Data…
Seres Therapeutics Inc. (NASDAQ: MCRB) Completes Enrolment in ECOSPOR IV SER-109…
Finance
Sesen Bion (NASDAQ: SESN) Completes Vicineum Commercialization Plans Ahead Of Approval
Brooklyn Immunotherapeutics Inc (NYSEAMERICAN:BTX) Clinches An Exclusive License mRNA Gene Editing…
Amarin Corporation Plc (NASDAQ:AMRN) Receives Marketing Authorization For Icosapent Ethyl From…
Hollywall Entertainment Inc (OTCMKTS:HWAL): Under-the-Radar NFT Star in the Making? (PLBY,…
GeoVax Labs (GOVX) surges on positive sentiment
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:MGNX
Tag: NASDAQ:MGNX
MacroGenics Inc. (NASDAQ:MGNX) Reports Its Q3 Financial Results and Clinical Updates...
Ward Sport
-
November 20, 2020
0
MacroGenics Inc. (NASDAQ:MGNX) Announce Publication Of Research Supporting flotetuzumab Study in...
Kate Hudson
-
June 11, 2020
0
MacroGenics Inc. (NASDAQ:MGNX) Gives Update OnBLA Review for Margetuximab In Treating...
Kate Hudson
-
June 4, 2020
0
Close
